Pfizer and BioNTech announced phase 3 trial data showing high efficacy of booster dose of COVID-19 vaccine
On Oct. 21, 2021, Pfizer and BioNTech announced topline results from a Phase 3 randomized, controlled trial evaluating…
-
-
INOVIO announced MOU with Colombia for protecting against COVID-19 and broader health initiatives
On Oct. 21, 2021, Inovio Pharma announced the signing of a non-binding memorandum of understanding with Colombia’s Ministry…
-
Johnson & Johnson COVID-19 vaccine booster shot authorized for Emergency Use by U.S. FDA
On Oct. 20, 2021, Johnson & Johnson announced the U.S. Food and Drug Administration (FDA) had issued an…
-
Quest Diagnostics provided K-12 School COVID-19 testing with Ginkgo Bioworks to support safer classrooms in Texas
On Oct. 20, 2021, Quest Diagnostics announced it had formed an agreement with the Texas Department of State…
-
Biotechnology | Diagnostics | Disease | NIH
NIH launched program to map a rare type of non-dividing cells implicated in human health and disease
On Oct. 20, 2021, the National Institutes of Health (NIH) launched a program to study a rare type…
-
Moderna announced FDA authorization of booster dose of COVID-19 vaccine in the U.S.
On Oct. 20, 2021, Moderna announced that the U.S. Food and Drug Administration (FDA) had authorized for emergency…
-
Progress in Xenotransplantation Opens Door to New Supply of Critically Needed Organs
On Oct. 19, 2021, the first investigational transplant of a genetically engineered, nonhuman kidney to a human body…
-
Study found that for the unvaccinated, reinfection by COVID-19 was likely
On Oct. 19, 2021, National Science Foundation funded scientists at the Yale School of Public Health and the…
-
Subcutaneous Interferon does not improve outcomes for hospitalized adults with COVID-19
On Oct. 18, 2021, a clinical trial has found that treatment with the immunomodulator interferon beta-1a plus the…
-
COVID-19 vaccine developed by Valneva using Dynavax’s CpG 1018 adjuvant met co-primary endpoints in phase 3 trial
On Oct. 18, 2021, Valneva, a specialty vaccine company, announced positive topline results from the Phase 3 pivotal…
-
U.S. FDA approved expanded indication of Gilead’s Biktarvy for Treatment of HIV-1 in pediatric populations
On Oct. 18, 2021, Gilead Sciences announced that the Food and Drug Administration had approved a new low-dose…
-
LogicBio Therapeutics announced early clinical trial results demonstrated first-ever in vivo genome editing in children
On Oct. 18, 2021, LogicBio Therapeutics announced clinical trial results demonstrating the first-ever in vivo genome editing in…
-
Athenex and Center for Cell and Gene Therapy announced allowance of first U.S. patent around CAR-NKT cell therapy
On Oct. 18, 2021, Athenex and the Center for Cell and Gene Therapy at Baylor College of Medicine,…
-
Pfizer and BioNTech submitted data to EMA for vaccination of children 5 to <12 years of age with COMIRNATY
On Oct. 18, 2021, Pfizer and BioNTech announced that the European Medicines Agency’s Committee for Human Medicinal Products…
-
Merck received positive CHMP opinion for VAXNEUVANCE (Pneumococcal 15-valent conjugate vaccine)
On Oct. 15, 2021, Merck announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use…
-
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics
FDA approved Roche’s Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer
On Oct. 15, 2021, Roche announced that the U.S. Food and Drug Administration (FDA) had approved Tecentriq (atezolizumab)…
-
Pfizer and BioNTech submitted data to EMA for vaccination of children 5 to <12 years of age with COMIRNATY
On Oct. 15, 2021, Pfizer and BioNTech announced they had submitted data supporting the vaccination of children 5…
-
FDA accepted REGEN-COV (casirivimab and imdevimab) for priority review for treatment and prophylaxis of COVID-19
On Oct. 14, 2021, Regeneron announced that the U.S. Food and Drug Administration (FDA) has accepted for priority…
-
Tuberculosis deaths rose for the first time in more than a decade due to the COVID-19 pandemic
On Oct. 14, 2021, the World Health Organization (WHO) announced that the COVID-19 pandemic had reversed years of…
-
Cepheid received CE Mark for Xpert Xpress CoV-2/Flu/RSV plus
On Oct. 14, 2021, Cepheid announced it had received the CE mark for Xpert Xpress CoV-2/Flu/RSV plus, a…
-
NIH RADx initiative expanded COVID-19 testing innovation for additional types of rapid tests
On Oct. 14, 2021, The National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative announced that…
-
Moderna announced FDA Advisory Committee unanimously voted in support of EUA for booster dose of COVID-19 vaccine
On Oct. 14, 2021, Moderna confirmed that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological…
-
Democratic Republic of the Congo started Ebola vaccination
On Oct. 13, 2021, the Ministry of Health of the Democratic Republic of the Congo announced that vaccination…
-
Biotechnology | COVID-19 | HIV | Life Science History | Non-Profit Research | Polio | Therapeutics | Vaccine | WHO
WHO bestowed posthumous award on the late Henrietta Lacks
On Oct. 13, 2021, the World Health Organization (WHO) honoured the late Henrietta Lacks with a WHO Director-General’s…
-
Moderna announced COVAX exercised option to purchase 176.5 million additional doses of Moderna’s COVID-19 vaccine
On Oct. 12, 2021, Moderna announced that Gavi, the Vaccine Alliance had exercised its option to purchase an…
-
INOVIO announced preprint publication of homologous boosting data for its COVID-19 DNA vaccine candidate INO-4800
On Oct. 12, 2021, Inovio Pharmaceuticals announced online preprint publication in MedRxiv of Phase 1 clinical data on…
-
Merck and Ridgeback announced Submission of EUA to the FDA for Molnupiravir, an Investigational Oral antiviral medicine, for treatment of COVID-19
On Oct. 11, 2021, Merck and Ridgeback Biotherapeutics announced that Merck had submitted an Emergency Use Authorization (EUA)…
-
Washington University School of Medicine reported antiviral compound blocked SARS-CoV-2 from entering cells
On Oct. 11, 2021, scientists at Washington University School of Medicine in St. Louis announced they had developed…
-
INOVIO expanded INNOVATE phase 3 for INO-4800 to include Colombia
On Oct. 11, 2021, Inovio Pharmaceuticals announced that it had received authorization from Colombia’s INVIMA, to conduct the…
-
Ebola case reported in the Democratic Republic of the Congo
On Oct. 8, 2021, the Ministry of Health of the Democratic Republic of the Congo announced that a…
